top of page
Clinical Trials
Real-time research. Real hope. Discover ongoing clinical trials for neurodegenerative diseases, cancer, CNS conditions, and more—all in one place.
Neurodegenerative Disease Trials
Explore real-time clinical trials for conditions like Alzheimer’s, Parkinson’s, Huntington’s, and ALS. These studies offer new possibilities for treatment, earlier intervention, and hope.
CNS Disorders Trials
Browse current studies for conditions like hydrocephalus, epilepsy, multiple sclerosis, and mental health disorders. Many of these trials focus on misunderstood or misdiagnosed disorders—offering options when you need them most.
Oncology Trials
Discover active clinical trials focused on cancers like ovarian, breast, glioblastoma, and more. Whether newly diagnosed or navigating a complex case, these trials could provide access to promising therapies and cutting-edge research.
Neurodegenerative Disease Trials
Can Metformin Help Prevent Alzheimer's?
​
This nationwide study is exploring whether metformin—a common diabetes medication—can help delay or even prevent Alzheimer’s in people with mild cognitive impairment.
If you or a loved one is experiencing early cognitive changes, this could be a proactive, research-driven option to consider.
​
Learn More HERE!
LEADS: Understanding Early-Onset Alzheimer’s
The LEADS study is working to better understand Alzheimer’s that starts earlier in life.
If you’re under 65 and experiencing memory problems, this study combines imaging, biomarkers, and clinical evaluations to uncover more about how this disease progresses—and how we might fight it.
​
Learn More Here!
Focused Ultrasound for Alzheimer's & Parkinson’s
​
This fascinating study uses focused ultrasound and advanced imaging to explore non-invasive ways to slow neurodegenerative conditions.
Researchers hope it could offer a whole new path for treating Alzheimer’s and Parkinson’s—without surgery.
​
Learn More Here!
CNS Disorders Trials
Semaglutide for Alcohol Use Disorder
​
This study evaluates the use of semaglutide, a medication commonly used for type 2 diabetes and obesity, in reducing alcohol consumption among individuals with alcohol use disorder. Participants will receive weekly injections and undergo regular assessments.
​
Learn More Here!
Ketamine Analog (PCN-101) for Treatment-Resistant Depression
​
This trial explores the efficacy of PCN-101, a ketamine analog, in individuals with treatment-resistant depression. The study aims to assess the rapid antidepressant effects of PCN-101 compared to placebo.
​
Learn More Here!
Oncology Trials
Intraoperative Radiotherapy for Brain Tumors
​
This Phase I/II study explores the use of intraoperative radiotherapy (IORT) during surgical resection of brain tumors.
The goal is to assess the safety and feasibility of delivering radiation therapy directly to the tumor bed during surgery, potentially improving local control and outcomes.
​
Learn More Here!
Sulindac for Lung Cancer Chemoprevention
​
This randomized Phase II trial investigates the potential of Sulindac, a nonsteroidal anti-inflammatory drug, in preventing lung cancer in high-risk individuals.
The study focuses on assessing the drug's effectiveness in reducing the incidence of lung cancer.
​
Learn More Here!
Niraparib Maintenance Therapy in Ovarian Cancer
​
This study evaluates the efficacy of Niraparib, a PARP inhibitor, as a maintenance therapy for patients with platinum-sensitive ovarian cancer.
The trial aims to determine if Niraparib can prolong progression-free survival in these patients.
​
Learn More Here!
​
bottom of page